Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
10/2010
10/14/2010WO2010116085A1 Cyclic peptides with an anti-parasitic activity
10/14/2010WO2010082175A3 Kxk-peptide compositions for cosmetic and dermo-pharmaceutic uses
10/14/2010US20100261914 Iap binding compounds
10/14/2010US20100261879 Peptide derivatives and cosmetic composition comprising the same
10/14/2010US20100261878 Sequences for fk228 biosynthesis and methods of synthesizing fk228 and fk228 analogs
10/14/2010US20100261876 Novel methods of synthesis for therapeutic antiviral peptides
10/14/2010US20100261871 Conformationally constrained peptide mimetics
10/14/2010US20100261658 Peptide for activating aquaporin synthesis
10/14/2010US20100261167 In vivo screen using chemical inducers of dimerization
10/14/2010US20100260828 Modulation of Platelet Aggregation
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758103A1 Cyclic peptides with an anti-parasitic activity
10/13/2010EP2239270A2 Low molecular weight peptide derivatives as inhibitors of the Laminin/Nidogen interaction
10/13/2010EP2239268A1 Dipeptide derivatives
10/13/2010EP2239267A1 Tag peptide and use thereof
10/13/2010CN101857632A Preparation and use of fatty acyl glycyl glycyl histidine-copper (II) complexes
10/13/2010CN101857631A Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/13/2010CN101190939B Oligopeptide-copper complex with blood vessel extending and thrombus dissolving activity and its preparation method and application
10/12/2010US7812117 stimulating the proliferation or survival of a hematopoietic cell exposed to a chemotherapeutic agent or irradiation; fusion polypeptide
10/12/2010US7812116 Immunogenic peptides
10/12/2010US7811992 Measuring binding of Bradykinin and angiogensin receptor; calibration; animal hibernation
10/12/2010US7811985 Treatment and prophylaxis of reperfusion injuries, particularly after cardiac necrosis; administering an N-terminus modified polypeptide derived from the A alpha chain of fibrinand the B beta chain of fibrin; antiinflammatory agents
10/12/2010US7811982 Compounds and methods for treating cancer
10/12/2010CA2383955C Extracorporeal endotoxin removal method
10/12/2010CA2338946C Hepatitis c inhibitor tri-peptides
10/07/2010WO2010115080A2 Self-assembling peptides bearing organic electronic functionality and applications employing the same
10/07/2010WO2010112713A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112712A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010112711A2 Novel proteasome-activating lightening peptides and compositions containing same
10/07/2010WO2010112710A2 Novel proteasome-activating anti-aging peptides and compositions containing same
10/07/2010WO2010111789A1 Inhibition of formation of advanced glycation endproducts
10/07/2010WO2010082176A3 Compositions containing kxk type peptides
10/07/2010US20100256049 Macrolactone derivatives
10/07/2010US20100256041 Conjugate Molecule Compounds With Enhanced Cell Uptake Activity
10/07/2010US20100255011 Compositions and methods for modulating the activity of complement regulatory proteins on target cells
10/07/2010US20100254994 Compositions and Methods for Binding or Inactivating Ghrelin
10/07/2010DE102009002044A1 Dipeptide als Futtermitteladditive Dipeptides as feed additives
10/06/2010EP2236611A1 Lipolytic enzyme variant
10/06/2010EP2235041A2 Antimicrobial compounds
10/06/2010EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds
10/06/2010CN1690047B 9-substituted minocycline compounds
10/06/2010CN101855235A Protective skin care tetrapeptides
10/06/2010CN101855207A Improved ramipril synthesis
10/05/2010US7807782 Using targeted reactions between proline and adapter segments as tool in generation of preferential fusion proteins; directed protein evolution
10/05/2010US7807781 Bactericides; viricides; administering antitrypsin peptide
10/05/2010US7807779 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration, tumor therapy
10/05/2010US7807681 Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807675 Hyaluronic acid-methotrexate conjugate
09/2010
09/30/2010WO2010109284A1 Antimicrobial cationic lipo-beta-peptides
09/30/2010WO2010068714A3 Deuterated compounds as hepatitis c virus (hcv) inhibitors
09/30/2010WO2010059051A3 Rapid fret-based diagnosis of bacterial pathogen
09/30/2010US20100249427 Bioluminescent protease assay
09/30/2010US20100249373 Screening methods
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249016 Metal-binding compounds and uses therefor
09/30/2010US20100247578 Carrier system for biological agents containing organosilicon compounds and uses thereof
09/30/2010US20100247463 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
09/29/2010EP2233137A2 Calcium receptor activator
09/29/2010EP2231152A2 Thienopyranones as kinase inhibitors
09/29/2010EP1569953B1 Peptide gap junction modulators
09/29/2010CN1867580B Compound modified with glycerol derivative
09/29/2010CN101848925A Biologically active C-terminal arginine-containing peptides
09/29/2010CN101845091A Metastin derivatives and use thereof
09/29/2010CN101845080A Angiotensin converting enzyme inhibitory peptide and preparation method thereof
09/29/2010CN101845079A Hexapeptide or derivative thereof and medical application thereof
09/29/2010CN101318992B Complete-basic amino acid oligopeptide, copper complex, synthesis method, self-assembly and application thereof
09/28/2010US7803777 conjugates of polyoxyethylene glycol with diverse therapeutic agents, e.g., peptides, lipids, glycolipids and small molecules; utility in biotechnology and medicine
09/28/2010US7803774 retro-inverso isomers of beta-amyloid peptides, used for diagnosis and treatment of amyloidogenic diseases such as Alzheimer's disease
09/28/2010US7803765 production and of nucleic acid fragment libraries that express highly diverse peptides, polypeptides or protein domains and, in particular, nucleic acid fragment libraries wherein the nucleic acid fragments are derived from two or more prokaryote genomes or compact eukaryote genomes
09/28/2010US7803757 For treatment of urinary tract infections and inflammations, colitis, and candida infections of mucosal membranes; infant formula food containing the peptide
09/28/2010US7803739 Substrates and assays for β-secretase
09/28/2010US7803566 Identifying T-cells in a sample that become activated in the presence of an amino acid sequence of a peptide with the same function as a CD8 T cell epitope of a vaccinia or variola virus; diagnosing vaccinia or variola virus infection by determining if the T-cells are activated by the peptide
09/28/2010US7803378 Antigen imitating extracellular areas of membrane proteins of type III produced from intracellular pathogenic micro-organisms, derived conformational antibodies and the use thereof
09/23/2010WO2010108172A1 Crystalline tripeptide epoxy ketone protease inhibitors
09/23/2010WO2010105363A1 Cyclic amino acid molecules and methods of preparing the same
09/23/2010US20100242141 Composition for production of plant body having improved sugar content, and use thereof
09/23/2010US20100240867 Fluorene compound
09/23/2010US20100240866 Modified gherlin peptides
09/23/2010US20100240865 Process for production of cyclic peptides
09/23/2010US20100240731 Lipopeptides for delivery of nucleic acids
09/23/2010US20100240598 Peptides and peptide mimetics to inhibit the onset and/or progression of fibrotic and/or pre-fibrotic pathologies
09/23/2010US20100240590 Peptides and related molecules that bind to tall-1
09/23/2010US20100240066 Compounds and methods for modulating cadherin-mediated processes
09/23/2010US20100239521 Method for the preparation of micro- and nano-sized carrier systems for the encapsulation of bioactive substances
09/23/2010CA2756804A1 Cyclic amino acid molecules and methods of preparing the same
09/23/2010CA2755971A1 Crystalline tripeptide epoxy ketone protease inhibitors
09/23/2010CA2755722A1 Gold (iii) complexes with oligopeptides functionalized with sulfur donors and use thereof as antitumor agents
09/22/2010EP2229935A1 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
09/22/2010EP2229400A1 Advantageous salts of mu-opiate receptor peptides
09/22/2010EP2229399A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
09/22/2010EP1725576B1 Positive modulator of bone morphogenic protein-2
09/22/2010EP1194449B1 Inhibitors of memapsin 2 and use thereof
09/22/2010CN101838628A Method for producing L-amino acids using bacteria belonging to the genus escherichia
09/22/2010CN101153052B Uridine peptide antibiotic, pharmaceutically acceptable salt, producing method and uses thereof
09/21/2010US7799896 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
09/21/2010US7799762 Functionally substituted amino acids, having fatty acid chains bound through amidification of the amine functional groups of dipeptide like compounds, one end bears a functional side chain and other side neutral or charged acid
09/21/2010US7799561 Affinity peptides and method for purification of recombinant proteins
09/21/2010CA2306692C Dipeptide apoptosis inhibitors and the use thereof
09/21/2010CA2290614C Process for the preparation of polymers having nucleobases as side groups
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 307